• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗失败的痛风患者的生活质量与残疾情况

Quality of life and disability in patients with treatment-failure gout.

作者信息

Becker Michael A, Schumacher H Ralph, Benjamin Katy L, Gorevic Peter, Greenwald Maria, Fessel Jeffrey, Edwards Lawrence, Kawata Ariane K, Frank Lori, Waltrip Royce, Maroli Allan, Huang Bill, Sundy John S

机构信息

Division of Biological Sciences, Rheumatology Section, University of Chicago, Chicago, IL, USA.

出版信息

J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30.

DOI:10.3899/jrheum.071229
PMID:19332629
Abstract

OBJECTIVE

The relationship between self-reported quality of life and disability and disease severity was evaluated in subjects with treatment-failure gout (n = 110) in a prospective, 52-week, observational study.

METHODS

Subjects had symptomatic crystal-proven gout of at least 2 years' duration and intolerance or refractoriness to conventional urate-lowering therapy. Serum uric acid (sUA) concentration, swollen and tender joint counts, frequency and severity of gout flares, tophus assessments, comorbidities, and patient-reported outcomes data [Medical Outcomes Study Short Form-36 (SF-36), Health Assessment Questionnaire-Damage Index] were collected. Analyses included correlations of patient-reported outcomes with clinical variables and changes in clinical status.

RESULTS

Mean age of study subjects was 59 years. Mean scores on SF-36 physical functioning subscales were 34.2-46.8, analogous to persons aged >or= 75 years in the general population. Subjects with more severe gout at baseline had worse health-related quality of life (HRQOL) in all areas (p < 0.02 for all measures), compared to patients with mild-moderate disease. Number of flares reported in past year, number of tender joints, swollen joints, and tophi correlated significantly with some or all HRQOL and disability measures. sUA was not significantly correlated with any HRQOL or disability measure. Subjects with comorbidities experienced worse physical, but not mental, functioning.

CONCLUSION

Severe gout is associated with poor HRQOL and disability, especially for patients who experience more gout flares and have a greater number of involved joints. Subject perceptions of gout-related functioning and pain severity appear to be highly sensitive indicators of HRQOL and disability.

摘要

目的

在一项为期52周的前瞻性观察性研究中,对110例治疗失败的痛风患者的自我报告生活质量与残疾及疾病严重程度之间的关系进行评估。

方法

研究对象有症状性经晶体证实的痛风,病程至少2年,对传统降尿酸治疗不耐受或难治。收集血清尿酸(sUA)浓度、肿胀和压痛关节计数、痛风发作频率和严重程度、痛风石评估、合并症以及患者报告的结局数据[医学结局研究简表36(SF-36)、健康评估问卷损伤指数]。分析包括患者报告结局与临床变量的相关性以及临床状态的变化。

结果

研究对象的平均年龄为59岁。SF-36身体功能分量表的平均得分在34.2至46.8之间,类似于普通人群中年龄≥75岁的人群。与轻中度疾病患者相比,基线时痛风更严重的患者在所有领域的健康相关生活质量(HRQOL)更差(所有测量指标p<0.02)。过去一年报告的发作次数、压痛关节数、肿胀关节数和痛风石与部分或所有HRQOL及残疾测量指标显著相关。sUA与任何HRQOL或残疾测量指标均无显著相关性。有合并症的患者身体功能较差,但心理功能无差异。

结论

严重痛风与较差的HRQOL和残疾相关,尤其是对于痛风发作更频繁且受累关节数量更多的患者。患者对痛风相关功能和疼痛严重程度的认知似乎是HRQOL和残疾的高度敏感指标。

相似文献

1
Quality of life and disability in patients with treatment-failure gout.治疗失败的痛风患者的生活质量与残疾情况
J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30.
2
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.在接受培戈洛酶治疗后,难治性慢性痛风患者的健康相关生活质量和身体功能得到改善:来自 III 期随机对照试验的证据。
J Rheumatol. 2012 Jul;39(7):1450-7. doi: 10.3899/jrheum.111375. Epub 2012 Jun 1.
3
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?慢性痛风的治疗。我们能否确定尿酸盐储存何时被充分消耗以预防痛风发作?
J Rheumatol. 2001 Mar;28(3):577-80.
4
Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.急性痛风发作患者的足部疼痛、功能障碍和残疾:一项前瞻性观察研究。
Arthritis Care Res (Hoboken). 2012 Mar;64(3):384-8. doi: 10.1002/acr.20670.
5
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.银屑病患者的生活质量:临床变量及银屑病特异性应激的作用
Br J Dermatol. 1997 Nov;137(5):755-60.
6
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.痛风与美国退伍军人更多的合并症、较差的健康相关生活质量以及更高的医疗保健利用率相关。
Ann Rheum Dis. 2008 Sep;67(9):1310-6. doi: 10.1136/ard.2007.081604. Epub 2008 Jan 4.
7
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.非布司他治疗痛风:FOCUS疗效与安全性研究的5年结果
Rheumatology (Oxford). 2009 Feb;48(2):188-94. doi: 10.1093/rheumatology/ken457.
8
Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.临床诊断的原发性痛风中与肌肉骨骼残疾和慢性肾衰竭相关的因素。
J Rheumatol. 2005 Oct;32(10):1923-7.
9
Health-related quality of life among haemodialysis patients--relationship with clinical indicators, morbidity and mortality.血液透析患者的健康相关生活质量——与临床指标、发病率和死亡率的关系
J Clin Nurs. 2006 Apr;15(4):498-504. doi: 10.1111/j.1365-2702.2006.01349.x.
10
Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.痛风患者的疾病认知与肌肉骨骼残疾进展的关系。
Arthritis Care Res (Hoboken). 2011 Nov;63(11):1605-12. doi: 10.1002/acr.20570.

引用本文的文献

1
Refractory Gout and Metabolic Syndrome in a Chinese Cohort: A Propensity Score Matching and Nonlinear Relationship Analysis.中国队列中的难治性痛风与代谢综合征:倾向评分匹配及非线性关系分析
J Inflamm Res. 2025 Aug 7;18:10573-10584. doi: 10.2147/JIR.S541062. eCollection 2025.
2
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.接受培戈洛酶治疗的痛风控制不佳的肾移植受者的生活质量改善及临床评估:4期PROTECT临床试验结果
Front Immunol. 2025 Mar 13;16:1516146. doi: 10.3389/fimmu.2025.1516146. eCollection 2025.
3
Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase.
在聚乙二醇化尿酸酶的临床试验期间,治疗引发的严重不良心血管和血栓栓塞事件并不常见。
Rheumatology (Oxford). 2025 Jun 1;64(6):3328-3333. doi: 10.1093/rheumatology/keaf017.
4
Quality of life and clinical gout assessments during pegloticase with and without methotrexate co-therapy: MIRROR randomized controlled trial exploratory findings.聚乙二醇化尿酸酶联合或不联合甲氨蝶呤治疗期间的生活质量和临床痛风评估:MIRROR随机对照试验的探索性结果。
Rheumatol Adv Pract. 2024 Nov 29;8(4):rkae145. doi: 10.1093/rap/rkae145. eCollection 2024.
5
Patient Experience with Chronic Refractory Gout and Its Impact on Health-Related Quality of Life: Literature Review and Qualitative Analysis.慢性难治性痛风患者的经历及其对健康相关生活质量的影响:文献综述与定性分析
Rheumatol Ther. 2024 Oct;11(5):1271-1290. doi: 10.1007/s40744-024-00697-8. Epub 2024 Aug 5.
6
The experiences and perspectives of people with gout on urate self-monitoring.痛风患者对尿酸自我监测的体验和看法。
Health Expect. 2024 Jun;27(3):e14071. doi: 10.1111/hex.14071.
7
Reliability and Validity of the Korean Version of the Gout Impact Scale.痛风影响量表韩国版的信度和效度。
J Korean Med Sci. 2023 Sep 4;38(35):e266. doi: 10.3346/jkms.2023.38.e266.
8
Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial.培戈洛酶联合甲氨蝶呤治疗难治性痛风患者的关节和患者报告健康评估的改善:MIRROR 开放性试验的 12 个月探索性结果。
Arthritis Res Ther. 2022 Dec 27;24(1):281. doi: 10.1186/s13075-022-02979-4.
9
Factors associated with change in health-related quality of life in people with gout: a 3-year prospective cohort study in primary care.与痛风患者健康相关生活质量变化相关的因素:初级保健中一项为期 3 年的前瞻性队列研究。
Rheumatology (Oxford). 2023 Aug 1;62(8):2748-2756. doi: 10.1093/rheumatology/keac706.
10
Surgical Treatment of Hand and Foot Gout Stone and Influence Factors on Prognosis.手足痛风石的手术治疗及对预后的影响因素。
Comput Math Methods Med. 2022 Sep 26;2022:4877708. doi: 10.1155/2022/4877708. eCollection 2022.